Aspirin Resistance Clinical Trial
Official title:
Prevalence of Aspirin Resistance in Hemodialysis Patients
Verified date | July 2013 |
Source | Northwell Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
Dialysis patient could be more aspirin resistant than the general population based on data from chronic kidney disease patients
Status | Completed |
Enrollment | 100 |
Est. completion date | November 2008 |
Est. primary completion date | November 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - all hemodialysis patients on aspirin Exclusion Criteria: - low platelets <100.000 - coagulopathy, bleeding disorders - patient on plavix |
Observational Model: Case Control, Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Northwell Health | Staten Island University Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Aspirin Resistance in Hemodialysis patients | 2 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01432652 -
The Efficacy of Aspirin in the Postoperative Period in Vascular Surgery
|
N/A | |
Completed |
NCT00948987 -
Mechanism Based Resistance to Aspirin
|
Phase 1 | |
Unknown status |
NCT01935193 -
Aspirin Resistance Reversibility in Diabetic Patients
|
Phase 4 | |
Not yet recruiting |
NCT01547039 -
Platelet Reactivity and MES During CEA
|
N/A | |
Completed |
NCT01159639 -
Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting
|
Phase 4 | |
Completed |
NCT00466154 -
The Effect of Serum LDL Lowering on Aspirin Resistance
|
N/A | |
Completed |
NCT01104441 -
Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia
|